News
Sarepta Therapeutics Inc. shares rose sharply early Tuesday after US regulators reversed course and recommended that patients who can walk be allowed to take its gene therapy Elevidys again.
Investor's Business Daily on MSN30m
Sarepta Stock Soars After FDA Says It Can Resume Drug Shipments
Sarepta stock rose sharply Tuesday after the Food and Drug Administration allowed the biopharma company to resume shipments ...
Revenue at SoFi jumps 44%, UnitedHealth slides after restoring financial guidance, and Sarepta soars after being notified by the FDA the company may lift its voluntary pause on shipments of Elevidys ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback